» Authors » Carlos Luzzani

Carlos Luzzani

Explore the profile of Carlos Luzzani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 307
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Amondarain M, Gallego I, Puras G, Saenz-Del-Burgo L, Luzzani C, Pedraz J
Trends Biotechnol . 2023 Jun; 41(11):1343-1359. PMID: 37302911
Exosome-based strategies constitute a promising tool for therapeutics, avoiding potential immunogenic and tumorigenic side-effects of cell therapies. However, the collection of a suitable exosome pool, and the need for high...
2.
Dominguez L, Bueloni B, Cantero M, Albornoz M, Pacienza N, Biani C, et al.
Int J Mol Sci . 2023 Jun; 24(11). PMID: 37298538
New therapeutic options for liver cirrhosis are needed. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) have emerged as a promising tool for delivering therapeutic factors in regenerative medicine. Our aim...
3.
Martire-Greco D, La Greca A, Montanez L, Biani C, Lombardi A, Birnberg-Weiss F, et al.
Shock . 2023 Apr; 59(6):941-947. PMID: 37036956
Background : Mesenchymal stem cells (MSCs) can be activated by different bacterial toxins. Lipopolysaccharides and Shiga Toxin (Stx) are the main toxins necessary for hemolytic uremic syndrome development. The main...
4.
Perez-Sosa C, Sanluis-Verdes A, Waisman A, Lombardi A, Rosero G, La Greca A, et al.
R Soc Open Sci . 2022 Mar; 9(1):211510. PMID: 35242349
Microfluidic tools have recently made possible many advances in biological and biomedical research. Research in fields such as physics, engineering, chemistry and biology have combined to produce innovation in microfluidics...
5.
Palma M, Luzzani C, Andrini L, Riccillo F, Buero G, Pelinski P, et al.
Cell Transplant . 2021 May; 30:963689721993774. PMID: 33975446
In normal physiological conditions, restoration of a functional epidermal barrier is highly efficient; nevertheless, when it fails, one of the main consequences is a chronic ulcerative skin defect, one of...
6.
La Greca A, Scarafia M, Hernandez Canas M, Perez N, Castaneda S, Colli C, et al.
PLoS One . 2020 May; 15(5):e0232715. PMID: 32369512
PIWI-interacting RNAs (piRNAs) are a class of non-coding RNAs initially thought to be restricted exclusively to germline cells. In recent years, accumulating evidence has demonstrated that piRNAs are actually expressed...
7.
Neiman G, Scarafia M, La Greca A, Santin Velazque N, Garate X, Waisman A, et al.
Sci Rep . 2019 Dec; 9(1):18077. PMID: 31792288
The stem cell niche has a strong influence in the differentiation potential of human pluripotent stem cells with integrins playing a major role in communicating cells with the extracellular environment....
8.
Waisman A, La Greca A, Mobbs A, Scarafia M, Santin Velazque N, Neiman G, et al.
Stem Cell Reports . 2019 Mar; 12(4):845-859. PMID: 30880077
Deep learning is a significant step forward for developing autonomous tasks. One of its branches, computer vision, allows image recognition with high accuracy thanks to the use of convolutional neural...
9.
Moro L, Amin G, Furmento V, Waisman A, Garate X, Neiman G, et al.
PLoS One . 2018 Dec; 13(12):e0207074. PMID: 30507934
Cell reprogramming has been well described in mouse and human cells. The expression of specific microRNAs has demonstrated to be essential for pluripotent maintenance and cell differentiation, but not much...
10.
La Greca A, Solari C, Furmento V, Lombardi A, Biani M, Aban C, et al.
Exp Mol Med . 2018 Sep; 50(9):1-12. PMID: 30201949
Mesenchymal stem/stromal cells (MSCs) obtained from pluripotent stem cells (PSCs) constitute an interesting alternative to classical MSCs in regenerative medicine. Among their many mechanisms of action, MSC extracellular vesicles (EVs)...